[{"address1": "Fitzwilliam Court", "address2": "1st Floor Leeson Close", "city": "Dublin", "zip": "D02 YW24", "country": "Ireland", "phone": "353 1 669 4820", "website": "https://www.iterumtx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.", "fullTimeEmployees": 14, "companyOfficers": [{"maxAge": 1, "name": "Mr. Corey N. Fishman", "age": 58, "title": "President, CEO & Director", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": 1372710, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Judith M. Matthews", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": 778817, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael W. Dunne M.D.", "age": 63, "title": "Strategic Advisor & Director", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 168148, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sailaja  Puttagunta M.D.", "age": 54, "title": "Chief Medical Officer", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": 755894, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tom  Loughman Ph.D.", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Louise  Barrett", "title": "Senior Vice President of Legal Affairs & Secretary", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven I. Aronin M.D.", "title": "Senior VP & Head of Clinical Development", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.44, "open": 1.44, "dayLow": 1.43, "dayHigh": 1.46, "regularMarketPreviousClose": 1.44, "regularMarketOpen": 1.44, "regularMarketDayLow": 1.43, "regularMarketDayHigh": 1.46, "beta": 2.363, "forwardPE": -1.3883495, "volume": 56736, "regularMarketVolume": 56736, "averageVolume": 623582, "averageVolume10days": 119000, "averageDailyVolume10Day": 119000, "bid": 1.41, "ask": 1.48, "bidSize": 300, "askSize": 300, "marketCap": 23490324, "fiftyTwoWeekLow": 0.622, "fiftyTwoWeekHigh": 2.5, "fiftyDayAverage": 1.5179, "twoHundredDayAverage": 1.29221, "currency": "USD", "enterpriseValue": 19069302, "floatShares": 15336046, "sharesOutstanding": 16426800, "sharesShort": 1225189, "sharesShortPriorMonth": 975307, "sharesShortPreviousMonthDate": 1709164800, "dateShortInterest": 1711584000, "sharesPercentSharesOut": 0.0746, "heldPercentInsiders": 0.01516, "heldPercentInstitutions": 0.07565, "shortRatio": 6.26, "shortPercentOfFloat": 0.076, "impliedSharesOutstanding": 16426800, "bookValue": -0.474, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -38371000, "trailingEps": -2.96, "forwardEps": -1.03, "lastSplitFactor": "1:15", "lastSplitDate": 1660780800, "enterpriseToEbitda": -0.417, "52WeekChange": 0.33644855, "SandP52WeekChange": 0.21231294, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ITRM", "underlyingSymbol": "ITRM", "shortName": "Iterum Therapeutics plc", "longName": "Iterum Therapeutics plc", "firstTradeDateEpochUtc": 1527255000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "2a47ad90-f2ae-3045-b6c4-2f53ded8d73b", "messageBoardId": "finmb_318354064", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.43, "targetHighPrice": 7.0, "targetLowPrice": 6.0, "targetMeanPrice": 6.5, "targetMedianPrice": 6.5, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 23930000, "totalCashPerShare": 1.457, "ebitda": -45718000, "totalDebt": 19509000, "quickRatio": 1.787, "currentRatio": 1.893, "returnOnAssets": -0.63738, "returnOnEquity": -3.55353, "freeCashflow": -22381250, "operatingCashflow": -39330000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-19"}]